Search results
Brokerage maintains buy on AstraZeneca shares, sees growth potential By Investing.com
Investing.com· 6 days agoOn Friday, TD Cowen affirmed its positive stance on AstraZeneca (NASDAQ:AZN), maintaining a Buy...
Celebrity doctors promoted Covid vaccine without declaring payments
The Telegraph via Yahoo News· 5 days agoThe pharmaceutical watchdog has been urged to investigate after a string of celebrity doctors took...
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 11 hours agoRivals Face Off With Regeneron Stock The companies are far from alone in the burgeoning COPD...
Centessa Pharma Hires CFO from Fusion After AstraZeneca Takeover
Market Watch· 3 days agoPublished: June 10, 2024 at 7:37 a.m. ETShareResizeBy Dean SealCentessa Pharmaceuticals has hired the former chief financial officer of Fusion Pharmaceuticals after the latter company was acquired ...
Making Tough Decisions: A Candid Discussion Between Oncs
Medscape· 18 hours agoDrs Mark Lewis and Don Dizon discuss what keeps them up at night.
Radiopharmaceuticals Are A Buzzy Area For Deal-Making
Crunchbase· 12 hours agoWhen reporting on startup investment, big funding rounds and M&A deals for pharmaceutical companies...
Mutation Mystery Solved: Why Lung Cancer Treatments Often Fail in Non-Smokers
SciTechDaily· 14 hours agoConducted by researchers from UCL, the Francis Crick Institute, and AstraZeneca, the study is...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 6 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
Meet The International Megacaps That 'Match Or Surpass' Magnificent Seven Stocks
Investor's Business Daily· 3 days agoInternational stocks, at large, are perking up in 2024. Novo Nordisk, ASML Holding, AstraZeneca, SAP...
Lung cancer: Why non-smokers don't respond to treatments
Medical News Today· 15 hours agoResearchers report that people who have never smoked are less likely to respond to standard...